BMC Medical Co. Hits Day Low of CNY 64.12 Amid Price Pressure

BMC Medical Co. experienced a notable decline today, with the stock dropping by 5.06% on March 23, 2026. The stock reached an intraday low of CNY 64.12, reflecting a challenging trading session. Over the past week, BMC Medical has seen a decrease of 10.04%, and its performance over the last month has been even more pronounced, with a decline of 16.73%. In comparison, the China Shanghai Composite index fell by 3.63% today, indicating that BMC Medical's downturn is more significant than the broader market trend. Year-to-date, the stock has decreased by 24.93%, and its three-year performance shows a substantial decline of 61.16%. Despite these recent challenges, BMC Medical Co. has reported positive financial metrics, including a net sales growth of 32.42% in the first half of the year and a return on capital employed (ROCE) of 7.28%. The company maintains a market capitalization of CNY 4,368 million and a price-to-earnings ratio of 54.00, reflecting its position within the pharmaceuticals and biotechnology industry.